bibliographic resource 3217295 [br/3217295]
https://w3id.org/oc/corpus/br/3217295

is a

• document
• article

title

• Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements on the Development of Novel Antidiabetes Drugs

publication date

• 2011-01-01

contributor

• https://w3id.org/oc/corpus/ar/12037145
• https://w3id.org/oc/corpus/ar/12037146
• https://w3id.org/oc/corpus/ar/12037147

format

• https://w3id.org/oc/corpus/re/1757505

identifier

• https://w3id.org/oc/corpus/id/6255191
• https://w3id.org/oc/corpus/id/6255192
• https://w3id.org/oc/corpus/id/6255193
• https://w3id.org/oc/corpus/id/6255194

part of

• https://w3id.org/oc/corpus/br/145994